Clinical Trial Site

Oklahoma City, Oklahoma 73120

2 studies enrolling now · 7 studies all time

What they study most

Acute Hepatic Porphyria, Dermatomyositis, Dravet Syndrome, Hearing Loss, Sensorineural, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Lennox Gastaut Syndrome, Noise Induced Hearing Loss, Sudden Hearing Loss, Tuberous Sclerosis Complex, Type 2 Diabetes Mellitus (T2DM)

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) — Recruiting now
• Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution — Running, not enrolling
• A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis — Running, not enrolling
• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM — Stopped early
• FX-322 in Adults With Acquired Sensorineural Hearing Loss — Completed